Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-07-29

FDA Approved: QBRELIS — Original Application (Azurity Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved QBRELIS (lisinopril) through an original NDA from Azurity Pharmaceuticals. It is indicated for hypertension, heart failure, and to improve surv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • QBRELIS (LISINOPRIL)

Snippet

ORIG AP for QBRELIS (LISINOPRIL)